The association of adherence to antiretroviral therapy with healthcare utilization and costs for medical care (Q37207523)

18 August 2017

The association of adherence to antiretroviral therapy with healthcare utilization and costs for medical care (English)

1 reference

18 August 2017

anti-retroviral agent

0 references

author name string

Edward M Gardner

1

1 reference

18 August 2017

Moises E Maravi

2

1 reference

18 August 2017

Cornelis Rietmeijer

3

1 reference

18 August 2017

Arthur J Davidson

4

1 reference

18 August 2017

William J Burman

5

1 reference

18 August 2017

1 January 2008

1 reference

Applied Health Economics and Health Policy

18 August 2017

1 reference

18 August 2017

6

1 reference

18 August 2017

2-3

1 reference

18 August 2017

145-155

1 reference

https://scigraph.springernature.com/pub.10.1007/bf03256129

18 August 2017

0 references

cites work

Adherence-resistance relationships to combination HIV antiretroviral therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688446

The cost-effectiveness of antiretroviral treatment in Khayelitsha, South Africa--a primary data analysis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688446

The Lifetime Cost of Current Human Immunodeficiency Virus Care in the United States

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688446

Durability of adherence to antiretroviral therapy on initial and subsequent regimens

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688446

Cost-effectiveness of highly active antiretroviral therapy in South Africa

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688446

A multicentre study of patient survival, disability, quality of life and cost of care: among patients with AIDS in northern Italy.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688446

Is there a baseline CD4 cell count that precludes a survival response to modern antiretroviral therapy?

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688446

Virologic and immunologic response, clinical progression, and highly active antiretroviral therapy adherence.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688446

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688446

Projecting the cost-effectiveness of adherence interventions in persons with human immunodeficiency virus infection

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688446

Denver Health: a model for the integration of a public hospital and community health centers

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688446

Adherence to protease inhibitor therapy and outcomes in patients with HIV infection

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688446

The costs of HIV antiretroviral therapy adherence programs and impact on health care utilization

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688446

Lifetime cost of HIV care in France during the era of highly active antiretroviral therapy.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688446

Cost of care for patients with human immunodeficiency virus infection. Patterns of utilization and charges in a public health care system

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688446

Distribution of health care expenditures for HIV-infected patients

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688446

Effectiveness and safety of a generic fixed-dose combination of nevirapine, stavudine, and lamivudine in HIV-1-infected adults in Cameroon: open-label multicentre trial

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688446

Methods for evaluating patient adherence to antidepressant therapy: a real-world comparison of adherence and economic outcomes.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688446

Selective drug taking during combination antiretroviral therapy in an unselected clinic population.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688446

Quality of life in HIV-infected individuals receiving antiretroviral therapy is related to adherence.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688446

Rapid viral load suppression following generic highly active antiretroviral therapy in Southern Indian HIV-infected patients

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688446

Comparing total health care costs and treatment patterns of HIV patients in a managed care setting

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688446

Generic antiretroviral drugs--will they be the answer to HIV in the developing world?

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688446

Effect of Medication Adherence on Survival of HIV-Infected Adults Who Start Highly Active Antiretroviral Therapy When the CD4+ Cell Count Is 0.200 to 0.350 × 109 cells/L

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688446

Non-adherence to highly active antiretroviral therapy predicts progression to AIDS.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688446

The cost effectiveness of combination antiretroviral therapy for HIV disease.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688446

Expenditures for the care of HIV-infected patients in the era of highly active antiretroviral therapy

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688446

Cost effectiveness of highly active antiretroviral therapy in HIV-infected patients. Swiss HIV Cohort Study.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688446

Multiple Range and Multiple F Tests

3 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF03256129

Assessing the cost-effectiveness of HAART for adults with HIV in England

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF03256129

Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF03256129

Thailand and the compulsory licensing of efavirenz

21 January 2018

1 reference

12 December 2020

[Cost-effectiveness of initial adherence to antiretroviral therapy among HIV infected patients in Belo Horizonte, Brazil]

1 reference

12 December 2020

Average wholesale price for prescription drugs: is there a more appropriate pricing mechanism?

1 reference

12 December 2020

Long-term impact of highly active antiretroviral therapy on HIV-related health care costs

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03256129

1 reference

18 August 2017

1 reference

18 August 2017

1 reference